Zacks Investment Research on MSN
AGIO secures global rights to late-stage rare blood disorder candidate
Agios Pharmaceuticals AGIO has inked an agreement with Oscotec, a South Korea-based biotech, in-licensing exclusive global ...
In what sounds like a horror movie, an 11-year-old Indian boy began inexplicably bleeding out of his eyes, nose and ears.
In a major step forward for long-form healthcare storytelling, Believe Limited has announced production on two feature-length documentary films focused on rare blood disorders, with support from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results